Literature DB >> 3127845

Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges.

J E Burch1, O Ahmed, R P Hullin, R H Mindham.   

Abstract

Seventy-four depressed patients were treated with amitriptyline for 4-6 weeks. Their doses were individually adjusted to maintain the sum of the plasma levels of amitriptyline (AT) and nortriptyline (NT) within one of three different ranges, randomly allocated. Allowance was made for individual plasma binding of the drugs. In the 50 patients between 25 and 65 years of age, the antidepressive response at low plasma drug levels was somewhat poorer than at medium or high levels, which were equally effective. In this age group an association was found between outcome and the individual rate of AT metabolism, expressed as "reciprocal clearance" (RC), the steady-state plasma concentration of AT plus NT divided by the daily AT dose. Good antidepressive outcome was associated with high RC. The implications of these findings for patient treatment and for the interpretation of other studies are discussed. The 18 patients between 65 and 80 years of age showed no significant differences between the effectiveness of treatment at different plasma drug levels, and no significant associations between outcome and RC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127845     DOI: 10.1007/bf00176845

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  The Leeds scales for the self-assessment of anxiety and depression.

Authors:  R P Snaith; G W Bridge; M Hamilton
Journal:  Br J Psychiatry       Date:  1976-02       Impact factor: 9.319

2.  Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.

Authors:  S Vandel; B Vandel; M Sandoz; G Allers; P Bechtel; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

Review 3.  Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.

Authors: 
Journal:  Am J Psychiatry       Date:  1985-02       Impact factor: 18.112

4.  A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: serum levels and clinical response.

Authors:  J Mendlewicz; P Linkowski; J A Rees
Journal:  Br J Psychiatry       Date:  1980-02       Impact factor: 9.319

5.  Plasma levels, psychophysiological variables, and clinical response to amitriptyline.

Authors:  U Breyer-Pfaff; H J Gaertner; H Giedke
Journal:  Psychiatry Res       Date:  1982-04       Impact factor: 3.222

6.  Amitriptyline metabolism in relation to antidepressive effect.

Authors:  P M Edelbroek; F G Zitman; J N Schreuder; H G Rooymans; F A de Wolff
Journal:  Clin Pharmacol Ther       Date:  1984-04       Impact factor: 6.875

7.  A clinical trial comparing sustained release amitryptyline (Saroten Retard) and conventional amitriptyline tablets (Saroten) in endogenously depressed patients with simultaneous determination of serum levels of amitryptyline and nortriptyline.

Authors:  P Liisberg; H Mose; A Amdisen; A Jørgensen; H E Petersen
Journal:  Acta Psychiatr Scand       Date:  1978-05       Impact factor: 6.392

8.  On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.

Authors:  G Jungkunz; H J Kuss
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1980-05

9.  A double blind comparison of zimelidine and amitriptyline in endogenous depression.

Authors:  S A Montgomery; R McAuley; S J Rani; D Roy; D B Montgomery
Journal:  Acta Psychiatr Scand Suppl       Date:  1981

10.  The antidepressant efficacy of zimelidine and maprotiline.

Authors:  S A Montgomery; S J Rani; R McAuley; D Roy; D B Montgomery
Journal:  Acta Psychiatr Scand Suppl       Date:  1981
View more
  5 in total

1.  Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression.

Authors:  Sven Ulrich; Jürgen Läuter
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Randomized exposure-controlled trials; impact of randomization and analysis strategies.

Authors:  Kristin E Karlsson; Anders Grahnén; Mats O Karlsson; E Niclas Jonsson
Journal:  Br J Clin Pharmacol       Date:  2007-04-10       Impact factor: 4.335

3.  Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.

Authors:  G L Corona; M L Cucchi; P Frattini; G Santagostino; S Schinelli; F Zerbi; F Savoldi
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  Low dosage tricyclic antidepressants for depression.

Authors:  T Furukawa; H McGuire; C Barbui
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 5.  Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications.

Authors:  L L von Moltke; D J Greenblatt; R I Shader
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.